Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Targeted therapy in lung cancer: molecular testing using cytological specimens].

Revue medicale suisse - 27 Jul 2011

Pusztaszeri M, Pache J-C, Mach N, Soccal P M, McKee T

Abstract excerpt

Important advances in lung cancer treatment have been made over the last decade. Several drugs designed to target molecular pathways involved in cancer-cell growth and survival have been shown to be effective in a selected fraction (<20%) of non-small cell lung cancer patients. Somatic mutations in several genes (i.e.: EGFR and KRAS) can predict patient's response to targeted therapies. Those mutations are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors
Share to KRAS gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Mutation

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Identifiers

PMID: 21899214

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Targeted therapy in lung cancer: molecular testing using cytological specimens].PMID 21899214Read ↗

Lung cancer in the era of targeted therapy: a cytologist's perspective.Semantic proximity Read ↗

Molecular diagnostics of lung carcinomas.Semantic proximity Read ↗

[Molecular diagnostics of lung cancer and its clinical relevance].Semantic proximity Read ↗

[Molecular pathologic diagnosis of lung cancer requires basic knowledge also from clinicians].Semantic proximity Read ↗

[Molecular genetic tests in advanced non-small cell lung cancer: practical relevance].Semantic proximity Read ↗

Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges.Semantic proximity Read ↗

[Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing].Semantic proximity Read ↗

EGFR analysis: current evidence and future directions.Semantic proximity Read ↗

Present and future molecular testing of lung carcinoma.Semantic proximity Read ↗

Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.Semantic proximity Read ↗

[Criteria of the molecular pathology testing of lung cancer].Semantic proximity Read ↗

[Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.